SEC Form 4 · accession 0001562180-17-000293
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kieran Gallahue
Director
Period of report
Jan 18, 2017
Accepted (ET)
Jan 20, 2017 · 7:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $13.05 | Jan 18, 2017 | A | 13,248 | A | — | Jan 17, 2027 | Common Stock | 13,248 | 13,248 | D |
Explanation of responses
- F1The shares subject to the option vest in 12 equal monthly installments commencing on January 1, 2017.